Recent advancement in drug development of nitro(NO2)-heterocyclic compounds as lead scaffolds for the treatment of Mycobacterium tuberculosis

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversity of Mississippi Medical Center (UMMC)-
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorScarim, Cauê Benito-
Autor(es): dc.creatorPavan, Fernando Rogério-
Data de aceite: dc.date.accessioned2025-08-21T16:05:43Z-
Data de disponibilização: dc.date.available2025-08-21T16:05:43Z-
Data de envio: dc.date.issued2022-05-01-
Data de envio: dc.date.issued2022-05-01-
Data de envio: dc.date.issued2021-12-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1002/ddr.21921-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/234100-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/234100-
Descrição: dc.descriptionTuberculosis (TB) is an infectious disease caused predominantly by Mycobacterium tuberculosis (Mtb). It was responsible for approximately 1.4 million deaths worldwide in 2019. The lack of new drugs to treat drug-resistant strains is a principal factor for the slow rise in TB infections. Our aim is to aid the development of new TB treatments by describing improvements (last decade, 2011–2021) to nitro(NO2)-based compounds that have shown activity or pharmacological properties (e.g., anti-proliferative, anti-kinetoplastid) against Mtb. For all compounds, we have included final correlations of minimum inhibitory concentrations against Mtb (H37Rv).-
Descrição: dc.descriptionDepartment of Cell and Molecular Biology University of Mississippi Medical Center (UMMC)-
Descrição: dc.descriptionSchool of Pharmaceutical Sciences Sao Paulo State University (UNESP), Sao Paulo-
Descrição: dc.descriptionSchool of Pharmaceutical Sciences Sao Paulo State University (UNESP), Sao Paulo-
Idioma: dc.languageen-
Relação: dc.relationDrug Development Research-
???dc.source???: dc.sourceScopus-
Título: dc.titleRecent advancement in drug development of nitro(NO2)-heterocyclic compounds as lead scaffolds for the treatment of Mycobacterium tuberculosis-
Tipo de arquivo: dc.typevídeo-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.